Pharmaceutical commercial sector continues to strengthen; Thalys Medical hits limit up.

The pharmaceutical commercial sector continues to strengthen, with Thalys Medical hitting the limit up, Baiyang Pharmaceutical rising over 15%, and Int Group, Yaoyigou, Shuyu Pingmin, Runda Medical, and Renmin Tongtai following the gains. In related ETFs, Pharma 50 ETF (Fuguo) rose 1.39% with a turnover of 1.6071 million yuan, and Pharma ETF (China Universal) rose 1.24% with a turnover of 16.7357 million yuan.